The role of complement in glomerulonephritis - are novel therapies ready for prime time?
Cheung, Chee Kay Dormer, John Barratt, Jonathan
Cheung, Chee Kay
Dormer, John
Barratt, Jonathan
Abstract
The complement system plays a key pathogenic role in glomerular diseases with a diverse range of aetiologies, including C3 glomerulopathy, IgA nephropathy, membranous nephropathy, ANCA associated vasculitis and lupus nephritis. Several novel therapies targeting complement activity have recently been developed, that have now been approved or are in the late stages of clinical development. In this review, potential benefits and challenges of targeting the complement system in glomerular disease are discussed. We summarise current understanding of the role of complement, and the novel targeted therapies that are being developed for the treatment of glomerular disease.
MIDER Authors
Affiliations
Citations
Altmetric:
Date
2022-10-28
Type
Article
Collections
Citation
Cheung, C. K., Dormer, J. P., & Barratt, J. (2022). The role of complement in glomerulonephritis - are novel therapies ready for prime time?. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, gfac296. Advance online publication. https://doi.org/10.1093/ndt/gfac296